Observational studyPloS one2017

Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial.

Ondrej Viklicky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.